Washington: The US Food and Drug Administration has approved a first-of-a-kind breast cancer medication that targets tumour cells while sparing healthy ones.The drug Kadcyla from Roche combines the established drug Herceptin with a powerful chemotherapy drug and a third chemical linking the medicines together. The chemical keeps the cocktail intact until it binds to a cancer cell, delivering a double-shot of anti-tumour poison.
Aamir Khan dares Salman Khan to drop his pants
High-tech car theft: Thieves clone key codes to steal cars
Students develop charger that charges as you walk!
Maharashtra CM Prithviraj Chavan not to share dais with Narendra Modi